摘要
恶性胸腔积液是一组临床常见综合征,恶性胸膜间皮瘤、肺癌、乳腺癌、淋巴瘤等是导致恶性胸腔积液的常见病因。尽管诊断方法和手段较多,但胸腔积液细胞沉淀中找到恶性细胞或在胸膜活检组织中观察到恶性肿瘤的病理改变仍然是确定恶性胸腔积液诊断的"金标准"。近年来多项研究结果倾向持续胸腔引流作为恶性胸腔积液治疗方法的首选,对多年来胸膜固定术的一线治疗地位提出了挑战。
Malignant pleural effusion（MPE） is a common clinical syndrome which usually caused by pleural mesothelioma, lung cancer, breast cancer, lymphoma and so on. There are multiple methods to diagnose MPE, but the ＂gold standard＂ way remains cytological identification of malignant cells within pleural effusion, or the pathology of the pleura1 biopsy specimen shows pathological manifestations of malignant tumor cells. Many studies shows that continues drainage of malignant pleural effusion becomes a first choice, which is a strong challenge for pleurodesis as the first-line therapy against MPE for years.
出处
《中国实用内科杂志》
CAS
CSCD
北大核心
2014年第8期765-766,共2页
Chinese Journal of Practical Internal Medicine
